Evidence based medicine in practice: lessons from a Scottish clinical genetics project

被引:16
作者
Campbell, H
Bradshaw, N
Davidson, R
Dean, J
Goudie, D
Holloway, S
Porteous, M
机构
[1] Western Gen Hosp, Dept Clin Genet, Edinburgh EH4 2XU, Midlothian, Scotland
[2] Yorkhill Hosp, Duncan Guthrie Dept Med Genet, Glasgow, Lanark, Scotland
[3] Dept Med Genet, Aberdeen, Scotland
[4] Ninewells Hosp, Dept Med Genet, Dundee DD1 9SY, Scotland
关键词
clinical guidelines; audit; evidence based medicine; care pathways;
D O I
10.1136/jmg.37.9.684
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Objective-To establish national clinical guidelines and integrated care pathways for five conditions (tuberous sclerosis (TS), Huntington's disease (HD), myotonic dystrophy (MD), neurofibromatosis type 1 (NF1), and Marfan syndrome (MS)) and audit their use in Scotland. Design-Systematic review of published reports followed by consensus conferences to prepare clinical guidelines and integrated care pathways. Structured review of medical records before and after introduction of integrated care pathways to document changes in practice. Survey of staff views on procedures adopted. Setting-All four clinical genetics centres in Scotland. Results-Project resulted in reduced variation in practice across centres, improved data recording in medical records, and improved communication with other professional groups. A very poor evidence base for management of patients with the conditions studied was found. Conclusions A collaborative structure for undertaking clinical research would improve the evidence base for current practice. National discussion of the boundaries of responsibility of care for the long term management of patients with these disorders is required. The integrated care pathway approach shows promise as a means of facilitating the development of audit within clinical genetics services.
引用
收藏
页码:684 / 691
页数:8
相关论文
共 17 条
[1]   Guidelines and care pathways for genetic diseases: the Scottish collaborative project on tuberous sclerosis [J].
Bradshaw, N ;
Brewer, C ;
FitzPatrick, D ;
Murray, G ;
Rodgers, F ;
Porteous, M ;
Campbell, H .
EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 (05) :445-458
[2]  
Campbell H, 1998, BMJ-BRIT MED J, V316, P133
[3]  
Clarke A, 1996, CLIN GENET, V50, P462
[4]  
*DEP HLTH, 1998, CANC GEN SERV SCOTL
[5]  
Ferguson JH, 1996, INT J TECHNOL ASSESS, V12, P460
[6]   CONSENSUS METHODS - CHARACTERISTICS AND GUIDELINES FOR USE [J].
FINK, A ;
KOSECOFF, J ;
CHASSIN, M ;
BROOK, RH .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1984, 74 (09) :979-983
[7]   The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2 [J].
Gutmann, DH ;
Aylsworth, A ;
Carey, JC ;
Korf, B ;
Marks, J ;
Pyeritz, RE ;
Rubenstein, A ;
Viskochil, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (01) :51-57
[8]  
Harris R, 1999, J MED GENET, V36, P350
[9]   HOW WELL DO WE MANAGE FAMILIES WITH GENETIC PROBLEMS [J].
HARRIS, R .
BRITISH MEDICAL JOURNAL, 1991, 303 (6815) :1412-1412
[10]   National Confidential Enquiry into counselling for genetic disorders by non-geneticists: general recommendations and specific standards for improving care [J].
Harris, R ;
Lane, B ;
Harris, H ;
Williamson, P ;
Dodge, J ;
Modell, B ;
Ponder, B ;
Rodeck, C ;
Alberman, E .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1999, 106 (07) :658-663